Novo Nordisk | NVO - Trade Creditors


Novo Nordisk reported DKK4.46B in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
ANI Pharmaceuticals USD 69.8M 15.23M Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Bausch Health Companies USD 600M 16M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Merck USD 4.15B 102M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Novo Nordisk DKK 4.46B 15.12B Jun/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Phibro Animal Health USD 133.3M 2.7M Dec/2025
Prestige Brands USD 42.95M 1.02M Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Zoetis USD 487M 77M Dec/2025